Clinical Trials in Illinois

Showing 15921-15940 of 19,692 trials

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

NCT00390234

This phase II trial is studying how well ziv-aflibercept works in treating patients with locally advanced, unresectable or metastatic gynecologic soft tissue sarcoma. Ziv-aflibercept may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more

National Cancer Institute (NCI)63 participantsStarted Sep 2006

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +13 more locations

COMPLETEDPhase 251 miles

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

NCT00809159

Evaluate the safety, tolerability and pharmacokinetics of AIN457 when administered as treatment of moderate to severe ankylosing spondylitis (AS).

Ankylosing Spondylitis

Novartis Pharmaceuticals60 participantsStarted Mar 2009

Paradise Valley, Arizona, United States • Springfield, Illinois, United States • Springfield, Illinois, United States +17 more locations

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Find Trials by Condition in Illinois

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Safety and Efficacy Study Comparing Thrombin for Arterial Sealing

Neurosurgery Patient Outcomes in Treating Spinal Disorders

Prehospital Resuscitation On Helicopter Study

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis